Orion Corporation Pharmaceutics
Orion Corporation Pharmaceutics is a globally operating Finnish pharmaceutical company. This company is a builder of well-being. It aims at developing, manufacturing, and marketing human as well as veterinary pharmaceuticals with active pharmaceutical ingredients. It is consistently developing new drugs and treatment methods. The core therapy areas of this trusted pharmaceutical company’s R&D are central nervous system disorders, oncology, and respiratory diseases. For respiratory diseases this company develops inhaled Easyhaler pulmonary drugs.
The customers of Orion Corporation Pharmaceutics are mainly healthcare service providers and professionals like specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics and laboratories. The main market for the leading company is Finland, where it is the clear market leader. All products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales covers almost all key European markets.
In other markets products of Orion Corporation Pharmaceutics are offered by several collaboration partners. Manufacturing plants and most of its R&D operations are in Finland whereas headquarters are in Espoo.
There are no products to list.